Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response

Interstitial lung disease (ILD) comprises a heterogenous group of diffuse lung disorders that commonly result in irreversible pulmonary fibrosis. While idiopathic pulmonary fibrosis (IPF) is the prototypical progressive fibrosing ILD (PF-ILD), a high proportion of patients with other ILD subtypes de...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowman, Willis S., Echt, Gabrielle A., Oldham, Justin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141562/
https://www.ncbi.nlm.nih.gov/pubmed/34041256
http://dx.doi.org/10.3389/fmed.2021.680997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141562/
https://www.ncbi.nlm.nih.gov/pubmed/34041256
http://dx.doi.org/10.3389/fmed.2021.680997

Ejemplares similares